Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 4
1970 2
1971 3
1972 2
1974 1
1977 1
1980 1
1981 1
1983 1
1984 1
1985 3
1986 2
1987 2
1988 3
1989 8
1990 5
1991 4
1992 3
1993 5
1994 7
1995 4
1996 4
1997 5
1998 3
1999 9
2000 5
2001 8
2002 7
2003 2
2004 5
2005 11
2006 14
2007 7
2008 5
2009 8
2010 6
2011 7
2012 4
2013 6
2014 1
2015 6
2016 3
2017 1
2018 3
2019 11
2020 4
2021 5
2022 8
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
Monk BJ, Parkinson C, Lim MC, O'Malley DM, Oaknin A, Wilson MK, Coleman RL, Lorusso D, Bessette P, Ghamande S, Christopoulou A, Provencher D, Prendergast E, Demirkiran F, Mikheeva O, Yeku O, Chudecka-Glaz A, Schenker M, Littell RD, Safra T, Chou HH, Morgan MA, Drochýtek V, Barlin JN, Van Gorp T, Ueland F, Lindahl G, Anderson C, Collins DC, Moore K, Marme F, Westin SN, McNeish IA, Shih D, Lin KK, Goble S, Hume S, Fujiwara K, Kristeleit RS. Monk BJ, et al. Among authors: lindahl g. J Clin Oncol. 2022 Dec 1;40(34):3952-3964. doi: 10.1200/JCO.22.01003. Epub 2022 Jun 6. J Clin Oncol. 2022. PMID: 35658487 Free PMC article. Clinical Trial.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators. Mirza MR, et al. Among authors: lindahl g. Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29. Lancet Oncol. 2019. PMID: 31474354 Clinical Trial.
[Cervical cancer is a clinical challenge].
Bjurberg M, Beskow C, Kannisto P, Lindahl G. Bjurberg M, et al. Among authors: lindahl g. Lakartidningen. 2015 Dec 8;112:DIUS. Lakartidningen. 2015. PMID: 26646957 Free article. Review. Swedish.
Structural biology: Variability without change.
Lindahl G, Persson JJ. Lindahl G, et al. Nat Microbiol. 2016 Oct 26;1(11):16218. doi: 10.1038/nmicrobiol.2016.218. Nat Microbiol. 2016. PMID: 27782137 No abstract available.
Water exposure--challenging differences between occupations.
Meding B, Anveden Berglind I, Alderling M, Lindahl G, Wrangsjö K. Meding B, et al. Among authors: lindahl g. Contact Dermatitis. 2016 Jan;74(1):22-8. doi: 10.1111/cod.12479. Epub 2015 Nov 18. Contact Dermatitis. 2016. PMID: 26579873
203 results